Selank Dosage Guide

Complete guide to Selank dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Intranasal administration: 250-500mcg 2-3 times daily. Subcutaneous: 250-500mcg daily.

Administration Method

Most commonly administered intranasally for cognitive effects. Can also be injected subcutaneously.

Side Effects to Monitor

Generally well-tolerated. Some users report mild fatigue or nasal irritation with intranasal use.

Safety Considerations & Risks

Limited Western clinical data. Primarily studied in Russia. Long-term effects not well documented.